William Ardrey
Director/Board Member at Resistys, Inc.
Profile
William J. Ardrey is a businessperson who has been the head of 12 different companies. Dr. Ardrey is on the board of Resistys, Inc. and Professor at the University of Adelaide, Professor at George Washington University, Professor at The University of Western Australia and Professor at Columbia University. In his past career William J. Ardrey held the position of Chairman, President & Chief Executive Officer at Avantogen Oncology, Inc., Chief Executive Officer at Alcon, Inc., President & Non-Executive Director at CustomVis Plc, President of LaserSight, Inc., Chief Executive Officer for SciClone Pharmaceuticals, Inc., President at Thomson Financial Services LLC, Chairman at Solbec Pharmaceuticals Ltd., Chief Executive Officer for Novartis, Inc., Chief Executive Officer of Acuvax Ltd., President at Regenera Ltd., Chief Executive Officer of QLT, Inc. and Chief Executive Officer of Avantogen Ltd.
William Ardrey active positions
Companies | Position | Start |
---|---|---|
The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | 2009-04-19 |
George Washington University | Corporate Officer/Principal | 2009-04-19 |
University of Adelaide | Corporate Officer/Principal | 2009-04-19 |
Resistys, Inc.
Resistys, Inc. Pharmaceuticals: MajorHealth Technology Part of Avantogen Oncology, Inc., Resistys, Inc. develops RP101, a pancreatic cancer drug aimed at preventing chemo-resistance for the North American market. The private company is based in Los Angeles, CA. | Director/Board Member | 2010-12-05 |
The University of Western Australia | Corporate Officer/Principal | 2011-09-15 |
Former positions of William Ardrey
Companies | Position | End |
---|---|---|
Acuvax Ltd.
Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | President | 2011-02-08 |
Solbec Pharmaceuticals Ltd. | Chairman | 2008-12-07 |
CustomVis Plc
CustomVis Plc Medical SpecialtiesHealth Technology CustomVis Plc manufactured and sold laser optical equipment for use within the laser vision correction industry. The company's products included CustomVisTM and PULZAR Z1TM. It was founded in March 2001 and headquartered in Perth, Australia. | President | 2006-05-21 |
Avantogen Ltd. | President | - |
░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ALCON INC. | Health Technology |
Private companies | 13 |
---|---|
SciClone Pharmaceuticals LLC
SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
LaserSight, Inc.
LaserSight, Inc. Electronic ComponentsElectronic Technology LaserSight, Inc. through its wholly-owned operating subsidiaries LaserSight Technologies, Inc. and LaserSight Patents, Inc engages in the development, manufacture & sale of ophthalmic lasers and related products primarily for use in laser vision correction, including laser in-situ keratomileusis & photorefractive keratectomy procedures. It also licenses patents related to refractive surgical procedures. The company was founded in 1987 and is headquartered in Winter Park, FL. | Electronic Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Health Technology |
CustomVis Plc
CustomVis Plc Medical SpecialtiesHealth Technology CustomVis Plc manufactured and sold laser optical equipment for use within the laser vision correction industry. The company's products included CustomVisTM and PULZAR Z1TM. It was founded in March 2001 and headquartered in Perth, Australia. | Health Technology |
Solbec Pharmaceuticals Ltd. | Health Technology |
Acuvax Ltd.
Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Health Technology |
Regenera Ltd. | Commercial Services |
Resistys, Inc.
Resistys, Inc. Pharmaceuticals: MajorHealth Technology Part of Avantogen Oncology, Inc., Resistys, Inc. develops RP101, a pancreatic cancer drug aimed at preventing chemo-resistance for the North American market. The private company is based in Los Angeles, CA. | Health Technology |
Avantogen Oncology, Inc.
Avantogen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Avantogen Oncology, Inc. operates as a development stage company. It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer. The company was founded in 1986 and is headquartered in Pasadena, CA. | Health Technology |
Avantogen Ltd. | Commercial Services |
Thomson Financial Services LLC
Thomson Financial Services LLC Life/Health InsuranceFinance Thomson Financial Services LLC offers insurance services. The firm assists employees on claim issues and educate on benefits of policies. It offers medical, dental, life, disability, and long term insurance services. The company is headquartered in Southington, CT. | Finance |
- Stock Market
- Insiders
- William Ardrey